dimarts, 6 de gener del 2015

NeuroSigma wins humanitarian designation from FDA for Monarch eTNS device




NeuroSigma makes progress in its bid to obtain a U.S. humanitarian device exemption for its therapy to treat a rare childhood brain disorder.





NeuroSigma wins humanitarian designation from FDA for Monarch eTNS device

NeuroSigma still needs a humanitarian device exemption for its therapy to treat a rare childhood brain disorder, but the FDA has taken it part of the way there.


Food & Drug Administration (FDA), NeuroSigma Inc

News Well, Humanitarian Device Exemption (HDE), Neuromodulation/Neurostimulation, Regulatory/Compliance

read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1BHBe9f
a

Cap comentari:

Publica un comentari a l'entrada